These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of hydroxyapatite granules in mastoid obliteration. Yung MW Clin Otolaryngol Allied Sci; 1996 Dec; 21(6):480-4. PubMed ID: 9118565 [TBL] [Abstract][Full Text] [Related]
3. Complications with hydroxyapatite cement in mastoid cavity obliteration. Ridenour JS; Poe DS; Roberson DW Otolaryngol Head Neck Surg; 2008 Nov; 139(5):641-5. PubMed ID: 18984257 [TBL] [Abstract][Full Text] [Related]
4. The use of demineralized bone matrix for mastoid cavity obliteration. Leatherman BD; Dornhoffer JL Otol Neurotol; 2004 Jan; 25(1):22-5; discussion 25-6. PubMed ID: 14724487 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of mastoid obliteration surgery. Minatogawa T; Machizuka H; Kumoi T Am J Otol; 1995 Jan; 16(1):99-103. PubMed ID: 8579186 [TBL] [Abstract][Full Text] [Related]
6. Open Mastoid Cavity Obliteration With a High-Porosity Hydroxyapatite Ceramic Leads to High Rate of Revision Surgery and Insufficient Cavity Obliteration. Weiss NM; Stecher S; Bächinger D; Schuldt T; Langner S; Zonnur S; Mlynski R; Schraven SP Otol Neurotol; 2020 Jan; 41(1):e55-e63. PubMed ID: 31584500 [TBL] [Abstract][Full Text] [Related]
7. Mastoid obliteration with hydroxyapatite--the value of high resolution CT scanning in detecting recurrent cholesteatoma. Yung MM; Karia KR Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):553-7. PubMed ID: 9466070 [TBL] [Abstract][Full Text] [Related]
8. [Tympanoplasty with mastoid obliteration using hydroxyapatite granules for aural cholesteatoma--a clinical and experimental study]. Takahashi S Nihon Jibiinkoka Gakkai Kaiho; 1991 Jun; 94(6):833-42. PubMed ID: 1653315 [TBL] [Abstract][Full Text] [Related]
9. Kang J; Oh SJ; Lee HM; Jeong KJ; Shin N; Lee IW; Lee J J Biomed Nanotechnol; 2017 Dec; 13(12):1715-1724. PubMed ID: 29490759 [TBL] [Abstract][Full Text] [Related]
10. Mid-temporal pericranial and inferiorly based periosteal flaps in mastoid obliteration. Yung M; Smith P Otolaryngol Head Neck Surg; 2007 Dec; 137(6):906-12. PubMed ID: 18036419 [TBL] [Abstract][Full Text] [Related]
11. Postauricular periosteal-pericranial flap for mastoid obliteration and canal wall down tympanomastoidectomy. Ramsey MJ; Merchant SN; McKenna MJ Otol Neurotol; 2004 Nov; 25(6):873-8. PubMed ID: 15547414 [TBL] [Abstract][Full Text] [Related]
17. A morphological study on obliteration of the temporal dorsal bullae using hydroxyapatite granules. Takahashi S; Nakano Y Am J Otol; 1996 Mar; 17(2):197-9. PubMed ID: 8723945 [TBL] [Abstract][Full Text] [Related]
18. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients. Vos J; de Vey Mestdagh P; Colnot D; Borggreven P; Orelio C; Quak J Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4121-4126. PubMed ID: 28956143 [TBL] [Abstract][Full Text] [Related]
19. Indications for and outcomes of mastoid obliteration in cochlear implantation. Leung R; Briggs RJ Otol Neurotol; 2007 Apr; 28(3):330-4. PubMed ID: 17414038 [TBL] [Abstract][Full Text] [Related]
20. Use of hydroxyapatite bone cement to prevent cerebrospinal fluid leakage through the frontal sinus: technical report. Ross DA; Marentette LJ; Thompson BG; Haller JS Neurosurgery; 1999 Aug; 45(2):401-2; discussion 402-3. PubMed ID: 10449089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]